NSC 830 Advanced Pharmacology Exam
Questions With Correct Answers
Combined |Oral |Contraceptives |(COCs) |- |CORRECT |ANSWER✔✔-Oral |contraceptives |containing |
both |estrogen |and |progestin
Progesterone |Only |Pills |(POPs) |- |CORRECT |ANSWER✔✔-Oral |contraceptives |containing |only |
progestin
No |protection |against |STIs |- |CORRECT |ANSWER✔✔-Characteristic |of |both |COCs |and |POPs
Higher |risk |of |venous |thromboembolism |(VTE) |- |CORRECT |ANSWER✔✔-Characteristic |of |COCs
No |suppression |of |lactation |- |CORRECT |ANSWER✔✔-Characteristic |of |POPs
Acceptable |with |history |of |migraines |with |aura |- |CORRECT |ANSWER✔✔-Characteristic |of |POPs
May |decrease |dysmenorrhea |- |CORRECT |ANSWER✔✔-Characteristic |of |both |COCs |and |POPs
Contraindicated |if |>35 |yo |& |smoker |- |CORRECT |ANSWER✔✔-Characteristic |of |COCs
Efficacy |may |be |decreased |if |taken |with |anticonvulsants |- |CORRECT |ANSWER✔✔-Characteristic
|of |COCs
May |improve |acne |- |CORRECT |ANSWER✔✔-Characteristic |of |COCs
, Fertility |re-established |immediately |after |discontinuing |- |CORRECT |ANSWER✔✔-Characteristic |
of |both |COCs |and |POPs
May |be |used |if |BP |consistently |elevated |- |CORRECT |ANSWER✔✔-Characteristic |of |POPs
Consider |the |patient's |personal |preference |- |CORRECT |ANSWER✔✔-Provider |should |consider |
the |patient's |personal |preference |to |encourage |adherence |to |contraception
Focus |on |choices |that |provide |the |highest |efficacy |rate |- |CORRECT |ANSWER✔✔-Provider |
should |focus |on |choices |that |provide |the |highest |efficacy |rate |to |encourage |adherence |to |
contraception
Screen |for |cervical |cancer |with |PAP |test |- |CORRECT |ANSWER✔✔-Provider |should |not |screen |
for |cervical |cancer |with |PAP |test |to |encourage |adherence |to |contraception
Suggest |a |long-term |option |since |she |is |nineteen |- |CORRECT |ANSWER✔✔-Provider |should |
suggest |a |long-term |option |since |the |patient |is |nineteen |to |encourage |adherence |to |
contraception
Combination |hormonal |contraceptives |(CHC) |reduce |fertility |by |- |CORRECT |ANSWER✔✔-
Producing |inflammatory |reaction |that |is |toxic |to |sperm, |thinning |cervical |mucous, |and |
inhibiting |ovulation
Producing |inflammatory |reaction |that |is |toxic |to |sperm |- |CORRECT |ANSWER✔✔-CHCs |reduce |
fertility |by |producing |inflammatory |reaction |that |is |toxic |to |sperm
Thinning |cervical |mucous |- |CORRECT |ANSWER✔✔-CHCs |reduce |fertility |by |thinning |cervical |
mucous
Inhibiting |ovulation |- |CORRECT |ANSWER✔✔-CHCs |reduce |fertility |by |inhibiting |ovulation
Questions With Correct Answers
Combined |Oral |Contraceptives |(COCs) |- |CORRECT |ANSWER✔✔-Oral |contraceptives |containing |
both |estrogen |and |progestin
Progesterone |Only |Pills |(POPs) |- |CORRECT |ANSWER✔✔-Oral |contraceptives |containing |only |
progestin
No |protection |against |STIs |- |CORRECT |ANSWER✔✔-Characteristic |of |both |COCs |and |POPs
Higher |risk |of |venous |thromboembolism |(VTE) |- |CORRECT |ANSWER✔✔-Characteristic |of |COCs
No |suppression |of |lactation |- |CORRECT |ANSWER✔✔-Characteristic |of |POPs
Acceptable |with |history |of |migraines |with |aura |- |CORRECT |ANSWER✔✔-Characteristic |of |POPs
May |decrease |dysmenorrhea |- |CORRECT |ANSWER✔✔-Characteristic |of |both |COCs |and |POPs
Contraindicated |if |>35 |yo |& |smoker |- |CORRECT |ANSWER✔✔-Characteristic |of |COCs
Efficacy |may |be |decreased |if |taken |with |anticonvulsants |- |CORRECT |ANSWER✔✔-Characteristic
|of |COCs
May |improve |acne |- |CORRECT |ANSWER✔✔-Characteristic |of |COCs
, Fertility |re-established |immediately |after |discontinuing |- |CORRECT |ANSWER✔✔-Characteristic |
of |both |COCs |and |POPs
May |be |used |if |BP |consistently |elevated |- |CORRECT |ANSWER✔✔-Characteristic |of |POPs
Consider |the |patient's |personal |preference |- |CORRECT |ANSWER✔✔-Provider |should |consider |
the |patient's |personal |preference |to |encourage |adherence |to |contraception
Focus |on |choices |that |provide |the |highest |efficacy |rate |- |CORRECT |ANSWER✔✔-Provider |
should |focus |on |choices |that |provide |the |highest |efficacy |rate |to |encourage |adherence |to |
contraception
Screen |for |cervical |cancer |with |PAP |test |- |CORRECT |ANSWER✔✔-Provider |should |not |screen |
for |cervical |cancer |with |PAP |test |to |encourage |adherence |to |contraception
Suggest |a |long-term |option |since |she |is |nineteen |- |CORRECT |ANSWER✔✔-Provider |should |
suggest |a |long-term |option |since |the |patient |is |nineteen |to |encourage |adherence |to |
contraception
Combination |hormonal |contraceptives |(CHC) |reduce |fertility |by |- |CORRECT |ANSWER✔✔-
Producing |inflammatory |reaction |that |is |toxic |to |sperm, |thinning |cervical |mucous, |and |
inhibiting |ovulation
Producing |inflammatory |reaction |that |is |toxic |to |sperm |- |CORRECT |ANSWER✔✔-CHCs |reduce |
fertility |by |producing |inflammatory |reaction |that |is |toxic |to |sperm
Thinning |cervical |mucous |- |CORRECT |ANSWER✔✔-CHCs |reduce |fertility |by |thinning |cervical |
mucous
Inhibiting |ovulation |- |CORRECT |ANSWER✔✔-CHCs |reduce |fertility |by |inhibiting |ovulation
